PTO- 1478 |
Approved for use through 09/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97044899 |
Filing Date: 09/24/2021 |
Input Field |
Entered |
SERIAL NUMBER | 97044899 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\970\448\97044899\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | 82 |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) orange/dark orange and white is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a design element consisting of two side-by-side circles representing tablets, half in white and half in orange/dark orange, superimposed over an oblong shape in white representing a capsule appearing above the number "82" also in white, which are both imprinted on an oblong capsule that is orange/dark orange in color. The broken lines depicting the shape of the capsule indicate placement of the mark on the goods. The capsule shape, depicted in broken lines, alone or separate from the other elements, is not claimed. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 719 x 480 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Merck Sharp & Dohme Corp. |
INTERNAL ADDRESS | Office of General Counsel |
*MAILING ADDRESS | One Merck Drive |
*CITY | Whitehouse Station |
*STATE (Required for U.S. applicants) |
New Jersey |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
08889 |
FAX | 732-594-5760 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | New Jersey |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | pharmaceutical preparations for the treatment of infectious diseases; antivirals; anti-infectives |
FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
ACTIVE PRIOR REGISTRATION(S) | The applicant claims ownership of active prior U.S. Registration Number(s) 2274462 and 5885773. |
ATTORNEY INFORMATION | |
NAME | Amy C. Van Eepoel |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Merck & Co., Inc. |
INTERNAL ADDRESS | Office of General Counsel |
STREET | 126 East Lincoln Avenue |
CITY | Rahway |
STATE | New Jersey |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 07065 |
PHONE | 732-594-4077 |
FAX | 732-594-5760 |
EMAIL ADDRESS | amy.van.eepoel@merck.com |
OTHER APPOINTED ATTORNEY | Lisa Jakob, Lisa M. Dellamura |
CORRESPONDENCE INFORMATION | |
NAME | Amy C. Van Eepoel |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | amy.van.eepoel@merck.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | Trademarkus@merck.com; kelly_panno@merck.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Jessica E. Stehr/ |
SIGNATORY'S NAME | Jessica E. Stehr |
SIGNATORY'S POSITION | Executive Director, Global Marketing |
DATE SIGNED | 09/24/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 09/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97044899 |
Filing Date: 09/24/2021 |
The applicant's current Correspondence Information: |
Amy C. Van Eepoel |
PRIMARY EMAIL FOR CORRESPONDENCE: amy.van.eepoel@merck.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): Trademarkus@merck.com; kelly_panno@merck.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|